EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...

Diabetic macular edema remains an important cause of vision loss among patients with diabetes mellitus. Improved control of blood pressure and blood sugar, as well as photocoagulation, are ...

Cystoid macular edema (CME) is a condition characterized ... The review highlighted various causes, including drug-induced cases, and emphasized the need for further investigation into treatment ...

Diabetic macular edema (DME) is a complication of diabetes. Over time, high blood sugar levels can cause damage to the tiny blood vessels in the eyes. Globally, about 5.5% of people with diabetes ...

Swelling caused due to excess fluid accumulation in ... Cerebral edema: Fluid collection in the brain. Macular edema: accumulation of fluid in macula, a part of the eye. Pregnancy - body tends ...

With DME being a leading cause of vision loss in diabetics and ... wet age-related macular degeneration (AMD) and diabetic macular edema (DME). Their lead product candidate, sozinibercept, is ...

Mississauga, Ontario Tuesday, January 21, 2025, 14:00 Hrs [IST] ...

Diabetic macular edema occurs when fluid leaks from blood ... Anti-VEGF injections block a protein that causes abnormal blood vessel growth. Your doctor injects medicine into your eye after ...

macular edema caused by a blockage in the retinal vein diabetic retinopathy diabetic macular edema Eylea is also used to treat retinopathy of prematurity, an eye condition that can affect ...

today announced that the first patient has been dosed in the OCU200 Phase 1 clinical trial for diabetic macular edema (DME). “OCU200 has the potential to change the treatment landscape for DME ...